Orbit CEO, Neil Butt, and Simon Bushell (Business Development) will be attending Bio Europe Spring in Milan, Italy from March 17th-19th.
They are available to connect to talk about how Orbit’s peptide discovery platform is delivering fully validated targeting peptides and functional modulators—helping both big pharma and biotech accelerate therapeutic development.